THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 125 filers reported holding THERAPEUTICSMD INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $16,000 | +33.3% | 42,791 | +23.5% | 0.00% | – |
Q4 2021 | $12,000 | -95.9% | 34,659 | -91.3% | 0.00% | – |
Q3 2021 | $296,000 | -35.2% | 399,670 | +4.1% | 0.00% | – |
Q2 2021 | $457,000 | +27.3% | 384,090 | +43.2% | 0.00% | – |
Q1 2021 | $359,000 | -14.7% | 268,300 | -23.0% | 0.00% | – |
Q4 2020 | $421,000 | +17.6% | 348,294 | +53.6% | 0.00% | – |
Q3 2020 | $358,000 | +15.9% | 226,711 | -8.5% | 0.00% | – |
Q2 2020 | $309,000 | +113.1% | 247,833 | +82.5% | 0.00% | – |
Q1 2020 | $145,000 | -56.6% | 135,785 | -1.7% | 0.00% | – |
Q4 2019 | $334,000 | -33.1% | 138,095 | +0.4% | 0.00% | – |
Q3 2019 | $499,000 | +14.7% | 137,512 | -17.7% | 0.00% | – |
Q2 2019 | $435,000 | -34.1% | 167,137 | +23.2% | 0.00% | -100.0% |
Q1 2019 | $660,000 | +32.0% | 135,657 | +3.5% | 0.00% | 0.0% |
Q4 2018 | $500,000 | -22.2% | 131,096 | +33.7% | 0.00% | 0.0% |
Q3 2018 | $643,000 | -26.2% | 98,057 | -29.8% | 0.00% | 0.0% |
Q2 2018 | $871,000 | +4.3% | 139,588 | -18.5% | 0.00% | 0.0% |
Q1 2018 | $835,000 | -10.9% | 171,376 | +10.5% | 0.00% | 0.0% |
Q4 2017 | $937,000 | +7.3% | 155,122 | -6.0% | 0.00% | 0.0% |
Q3 2017 | $873,000 | +100.2% | 165,017 | +99.5% | 0.00% | – |
Q2 2017 | $436,000 | -29.0% | 82,722 | -2.9% | 0.00% | -100.0% |
Q1 2017 | $614,000 | -16.9% | 85,222 | -33.5% | 0.00% | 0.0% |
Q4 2016 | $739,000 | +5.4% | 128,097 | +24.4% | 0.00% | 0.0% |
Q3 2016 | $701,000 | -29.7% | 103,003 | -12.2% | 0.00% | 0.0% |
Q2 2016 | $997,000 | +146.8% | 117,293 | +85.8% | 0.00% | – |
Q1 2016 | $404,000 | -23.3% | 63,133 | +24.3% | 0.00% | -100.0% |
Q4 2015 | $527,000 | +60.7% | 50,771 | -9.1% | 0.00% | – |
Q3 2015 | $328,000 | -70.5% | 55,875 | -60.4% | 0.00% | -100.0% |
Q2 2015 | $1,110,000 | +212.7% | 141,208 | +141.2% | 0.00% | – |
Q1 2015 | $355,000 | -5.1% | 58,538 | -30.3% | 0.00% | – |
Q4 2014 | $374,000 | -10.7% | 83,965 | -7.1% | 0.00% | – |
Q3 2014 | $419,000 | +79.8% | 90,366 | +71.8% | 0.00% | – |
Q2 2014 | $233,000 | -69.4% | 52,595 | -56.5% | 0.00% | -100.0% |
Q1 2014 | $762,000 | +156.6% | 120,781 | +111.9% | 0.00% | – |
Q4 2013 | $297,000 | +330.4% | 57,004 | +149.9% | 0.00% | – |
Q2 2013 | $69,000 | – | 22,812 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,460,225 | $24,914,000 | 4.95% |
Newtyn Management, LLC | 1,800,000 | $12,960,000 | 1.95% |
1492 Capital Management LLC | 222,485 | $1,602,000 | 1.25% |
SANDERS MORRIS HARRIS LLC | 967,200 | $6,964,000 | 1.18% |
MORGENS WATERFALL VINTIADIS & CO INC | 180,000 | $1,296,000 | 1.15% |
SPHERA FUNDS MANAGEMENT LTD. | 580,000 | $4,176,000 | 0.82% |
Rock Springs Capital Management LP | 1,600,000 | $11,520,000 | 0.66% |
STONERIDGE INVESTMENT PARTNERS LLC | 467,425 | $3,365,000 | 0.45% |
Capital Impact Advisors, LLC | 157,411 | $1,133,000 | 0.45% |
GILDER GAGNON HOWE & CO LLC | 3,059,690 | $22,030,000 | 0.37% |